PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-23.20%
Both yoy net incomes decline, with BTE at -16.47%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
3.21%
Less D&A growth vs. BTE's 14.63%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-66.67%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-230.43%
Negative yoy SBC while BTE is 22.95%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
19.38%
Slight usage while BTE is negative at -317.68%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-52.86%
AR is negative yoy while BTE is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
29.57%
Some yoy usage while BTE is negative at -317.68%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-2600.00%
Negative yoy while BTE is 22.49%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
105.66%
Some CFO growth while BTE is negative at -12.99%. John Neff would note a short-term liquidity lead over the competitor.
-4.01%
Negative yoy CapEx while BTE is 48.36%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
286.05%
Acquisition spending well above BTE's 275.00%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
4.01%
Purchases growth of 4.01% while BTE is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-56.36%
We reduce yoy sales while BTE is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-4.01%
Both yoy lines negative, with BTE at -36.21%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
19.64%
Lower net investing outflow yoy vs. BTE's 49.28%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
-50.00%
We cut debt repayment yoy while BTE is 90.74%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.